Records containing: Multiple Sclerosis, Relapsing-Remitting
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-10-08Single-Arm, Non-Randomized, Time Series, Single-Subject Study: Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-05-26An Open-Label Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Relapsing Remitting Multiple Sclerosis Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment
-
CLINICAL_TRIALS study record update · 2020-05-13Light Therapy as Treatment for Fatigue in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-02-24Evaluating the Use of Acute Intermittent Hypoxia to Improve Symptoms in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-02-10Evaluation of clINical reCovery After a Relapse: a Pilot Study assEssing the Neuronal Effects of D-Aspartate in RR-MS Subjects Treated With IntErferon Beta 1a 44 mcg TIW (INCREASE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-01-03Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-12-12Phase I Study of Oral Guanabenz for Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-12-09A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
-
CLINICAL_TRIALS study record update · 2019-11-22A Multicenter Extension Study to Determine the Long-Term Safety and Efficacy of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-11-01Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2019-10-10To Investigate the Effect of Aerobic Exercise on Neurophysiological Values and Functionality in Individuals With Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2019-10-08Randomized, Controlled Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-09-25Subcutaneous (SC) Interferon Beta Therapy in Multiple Sclerosis Patients and Characterization of Injection Site Reactions and Flu-Like Symptoms Under Daily Practice Setting
-
CLINICAL_TRIALS study record update · 2019-08-13The Effect of ACTH (Acthar) on Measures of Chronic Fatigue in Patients With Relapsing Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2019-07-22Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
-
CLINICAL_TRIALS study record update · 2019-06-27An Open-Label Study to Assess the Effects of BG00012 on Lymphocyte Subsets in Subjects With Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-03-20Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-01-09Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate SURV-SEP
-
CLINICAL_TRIALS study record update · 2018-11-27Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2018-11-21The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test Test in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2018-10-11A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
-
CLINICAL_TRIALS study record update · 2018-09-20Multicenter, Open-label, 12 Week, Phase IV Prospective Randomized Study Aimed at Evaluating Whether sc IFN Beta 1a (Rebif®) Administered in the Morning May Affect the Severity of Flu-like Syndrome and Patient-perceived Invisible Symptoms in Subjects With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2018-09-20Effects Aquatic Exercises on Balance and Hand Function in Multiple Sclerosis: Halliwick Versus Aquatic Plyometric Exercises
-
CLINICAL_TRIALS study record update · 2018-09-06Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
-
CLINICAL_TRIALS study record update · 2018-06-06A Phase IIIB, Multicenter, Randomized, Parallel-Group, Open-Label Study to Evaluate the Effects of Ocrelizumab on Immune Responses in Patients With Relapsing Forms of Multiple Sclerosis